Biohit Oyj operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biohit Oyj with three other
pharmaceutical manufacturers in Europe:
sales of 4.20 million Euro [US$4.90 million]
of which 53%
was Product sales (own and third party)),
IDL Biotech AB
(33.49 million Swedish Kronor [US$4.08 million]
RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS
based in Turkey
(31.81 million Turkish Liras [US$8.91 million]
Biohit Oyj reported sales of 8.20 million Euro (US$9.56 million)
December of 2016.
increase of 35.5%
versus 2015, when the company's sales were 6.05 million Euro.
This was the fourth straight year of sales growth at Biohit Oyj.